Skip to content
Screener

Hims & Hers Health HIMS Stock-Based Comp

Stock-Based Comp at other companies

WW International, Inc. logo
WW International, Inc.WW
$449K
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$1.45M-43.1%
Amazon logo
AmazonAMZN
$6.04B-7.6%
Teladoc Health logo
Teladoc HealthTDOC
$9.3M-58.4%
Veradermics
 logo
Veradermics MANE
$5.26M+2,369%
PBH
Prestige Consumer HealthcarePBH
$3.99M+8.5%

Other financials

Income statement

See full
Revenue$608.1M+3.8%
Gross profit$396.8M-7.9%
Operating income-$78.3M-235%
Net income-$92.1M-286%
EPS (diluted)-$0.40-300%

Balance sheet

See full
Cash & equivalents$222.3M-19.2%
Total debt$157.9M+149%
Total equity$446.2M-18.8%
Total assets$2.3B+154%

Cash flow

See full
Operating cash flow$89.4M-18.1%
CapEx$8.8M-19.9%
Free cash flow$80.5M-17.9%

Valuation

See full
Market cap$7.44B-36.6%
Enterprise value$7.38B-30.9%
P/S3.1×-2.7×

Profitability

See full
Gross margin71.7%-5.3pp
Operating margin-1.3%-7.5pp
Net margin-0.6%-9.8pp
FCF margin11.9%-5.8pp

Returns & leverage

See full
Return on equity-2.7%-39.4pp
Debt / equity0.4×+0.2×
Current ratio1.7×+0.1×

Where this comes from

Reported directly by Hims & Hers Health in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Hims & Hers Health’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001773751-26-000076
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net (loss) income$(92,115)$49,485
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization21,9538,276
Stock-based compensation36,86224,858
Change in fair value of equity securities9,682
Change in fair value of liabilities17,646
Net accretion on securities(242)(693)
Benefit from deferred taxes(13,975)(890)

Item 1. Financial Statements

FAQ

What is Hims & Hers Health's stock-based comp?
Hims & Hers Health (HIMS) reported stock-based comp of $36.86M in Q1 2026.
How has Hims & Hers Health's stock-based comp changed year-over-year?
Hims & Hers Health's stock-based comp increased by 48.3% year-over-year, from $24.86M to $36.86M.
What is the long-term trend for Hims & Hers Health's stock-based comp?
Over 4 years (2021 to 2025), Hims & Hers Health's stock-based comp has grown at a 19.1% compound annual growth rate (CAGR), from $67.21M to $135.24M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Hims & Hers Health's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude